Loading the session
Loading the session
Loading instrument
$104.67
−3.31%Market closedDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 06:29 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
3 Nov 2026 volume of 19.7M shares was 4.2× the average of the 30 sessions before it (4.7M), as the price fell 3.5%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
50.6M shares were sold short at the 15 Oct 2026 settlement, 15.2% of the 332.6M shares outstanding; covering them would take 10.2 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
The 3 Nov 2026 close of $104.46 was 1.8% above its 50-day average ($102.66) and 1.4% above its 200-day average ($103.06). It has closed above the 200-day for 14 sessions, since 15 Oct 2026. The 50-day average crossed below the 200-day on 27 Oct 2026, 5 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
1 month: +9.5% (SPY −2.6%, XLB +6.2%). 3 months: −6.4% (SPY −2.2%, XLB +1.1%). 1 year: +2.1% (SPY +10.4%, XLB +23.5%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: KMB, SPY and XLB · as of 3 Nov 2026
Closed at $104.46 on 3 Nov 2026: 10.6% below the 52-week high of $116.82 (7 Jul 2026) and 13.0% above the low of $92.42 (7 Apr 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Price return, split-adjusted
At the 3 Nov 2026 close
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
November 3, 2025
−14.57%July 23, 2024
−5.73%April 22, 2022
+8.13%